The Natural Cytotoxicity Receptors in Health and Disease

Exploiting NK Cell Surveillance Pathways for Cancer Therapy

(2019) Alexander Barrow et al.   Cancers

Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor

(2018) Alexander D. Barrow et al.   CELL

NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis

(2018) Ariella Glasner et al.   IMMUNITY

Haemagglutinin-neuraminidase from HPIV3 mediates human NK regulation of T cell proliferation via NKp44 and NKp46

(2018) Samantha McQuaid et al.   JOURNAL OF GENERAL VIROLOGY

NKp46 Calibrates Tumoricidal Potential of Type 1 Innate Lymphocytes by Regulating TRAIL Expression

(2018) Gleb Turchinovich et al.   JOURNAL OF IMMUNOLOGY

Cutting Edge: Check Your Mice—A Point Mutation in theNcr1Locus Identified in CD45.1 Congenic Mice with Consequences in Mouse Susceptibility to Infection

(2018) Youngsoon Jang et al.   JOURNAL OF IMMUNOLOGY

Rewiring T-cell responses to soluble factors with chimeric antigen receptors

(2018) ZeNan L Chang et al.   Nature Chemical Biology

Distinct human circulating NKp30+FcεRIγ+CD8+T cell population exhibiting high natural killer-like antitumor potential

(2018) Margareta P. Correia et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Identification of the fungal ligand triggering cytotoxic PRR-mediated NK cell killing of Cryptococcus and Candida

(2018) Shu Shun Li et al.   Nature Communications

The Murine Natural Cytotoxic Receptor NKp46/NCR1 Controls TRAIL Protein Expression in NK Cells and ILC1s

(2018) Sam Sheppard et al.   Cell Reports

The role of Galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment

(2018) Mohammad Farhad et al.   OncoImmunology

Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptor

(2018) Silvia Gaggero et al.   OncoImmunology

Deficient natural killer cell NKp30-mediated function and altered NCR3 splice variants in hepatocellular carcinoma

(2018) Stefania Mantovani et al.   HEPATOLOGY

β1 Integrins Are Required To Mediate NK Cell Killing of Cryptococcus neoformans

(2018) Richard F. Xiang et al.   JOURNAL OF IMMUNOLOGY

Human anti‐NKp46 antibody for studies of NKp46‐dependent NK cell function and its applications for type 1 diabetes and cancer research

(2018) Orit Berhani et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice

(2018) Adeline Crinier et al.   IMMUNITY

Heparan sulfate as a regulator of inflammation and immunity

(2018) Laura E. Collins et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Molecular definition of group 1 innate lymphoid cells in the mouse uterus

(2018) Iva Filipovic et al.   Nature Communications

Innate lymphoid cell sensing of tissue vitality

(2018) Alexander David Barrow et al.   CURRENT OPINION IN IMMUNOLOGY

Polymerase δ-interacting Protein 2

(2017) Marina S. Hernandes et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Cutting Edge: Human CD49e−NK Cells Are Tissue Resident in the Liver

(2017) Han Xian Aw Yeang et al.   JOURNAL OF IMMUNOLOGY

The prognostic value of B7-H6 protein expression in human oral squamous cell carcinoma

(2017) Jiongke Wang et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

NKp46 Recognizes the Sigma1 Protein of Reovirus: Implications for Reovirus-Based Cancer Therapy

(2017) Yotam Bar-On et al.   JOURNAL OF VIROLOGY

A distinct innate lymphoid cell population regulates tumor-associated T cells

(2017) Sarah Q Crome et al.   NATURE MEDICINE

The hemagglutinin-neuramidinase protein of Newcastle disease virus upregulates expression of the TRAIL gene in murine natural killer cells through the activation of Syk and NF-κB

(2017) Ying Liang et al.   PLoS One

Development of unique cytotoxic chimeric antigen receptors based on human scFv targeting B7H6

(2017) Casey K Hua et al.   PROTEIN ENGINEERING DESIGN & SELECTION

Tailoring Natural Killer cell immunotherapy to the tumour microenvironment

(2017) Alexander David Barrow et al.   SEMINARS IN IMMUNOLOGY

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis

(2017) Sara Trabanelli et al.   Nature Communications

Regulation of the Functions of Natural Cytotoxicity Receptors by Interactions with Diverse Ligands and Alterations in Splice Variant Expression

(2017) Tatiana Pazina et al.   Frontiers in Immunology

Targeting Multiple Tumors Using T-Cells Engineered to Express a Natural Cytotoxicity Receptor 2-Based Chimeric Receptor

(2017) Vasyl Eisenberg et al.   Frontiers in Immunology

Nidogen-1 Degraded by Cathepsin S can be Quantified in Serum and is Associated with Non–Small Cell Lung Cancer

(2017) Nicholas Willumsen et al.   NEOPLASIA

Human cytomegalovirus escapes immune recognition by NK cells through the downregulation of B7-H6 by the viral genes US18 and US20

(2017) Yoav Charpak-Amikam et al.   Scientific Reports

Increased NK cell immunity in a transgenic mouse model of NKp46 overexpression

(2017) Ariella Glasner et al.   Scientific Reports

On the road to nowhere: cross-talk between post-translational protein targeting and cytosolic quality control

(2016) J. Casson et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

NK Cell Recognition of Candida glabrata through Binding of NKp46 and NCR1 to Fungal Ligands Epa1, Epa6, and Epa7

(2016) Alon Vitenshtein et al.   Cell Host & Microbe

Delta One T Cells for Immunotherapy of Chronic Lymphocytic Leukemia: Clinical-Grade Expansion/Differentiation and Preclinical Proof of Concept

(2016) A. R. Almeida et al.   CLINICAL CANCER RESEARCH

Interleukin-15-Dependent T-Cell-like Innate Intraepithelial Lymphocytes Develop in the Intestine and Transform into Lymphomas in Celiac Disease

(2016) Julien Ettersperger et al.   IMMUNITY

Transforming Growth Factor-β Signaling Guides the Differentiation of Innate Lymphoid Cells in Salivary Glands

(2016) Victor S. Cortez et al.   IMMUNITY

Phenotypic and Functional Plasticity of Murine Intestinal NKp46+Group 3 Innate Lymphoid Cells

(2016) Thomas Verrier et al.   JOURNAL OF IMMUNOLOGY

The glycocalyx and its significance in human medicine

(2016) J. M. Tarbell et al.   JOURNAL OF INTERNAL MEDICINE

Human Herpesvirus 6B Downregulates Expression of Activating Ligands during Lytic Infection To Escape Elimination by Natural Killer Cells

(2016) Dominik Schmiedel et al.   JOURNAL OF VIROLOGY

Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis

(2016) Christoph S N Klose et al.   NATURE IMMUNOLOGY

Natural Killer Receptor 1 Dampens the Development of Allergic Eosinophilic Airway Inflammation

(2016) Shirin Elhaik Goldman et al.   PLoS One

Structural basis of collagen recognition by human osteoclast-associated receptor and design of osteoclastogenesis inhibitors

(2016) Joel Haywood et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

NKp44 and NKp30 splice variant profiles in decidua and tumor tissues: a comparative viewpoint

(2016) Avishai Shemesh et al.   Oncotarget

Survival in acute myeloid leukemia is associated with NKp44 splice variants

(2016) Avishai Shemesh et al.   Oncotarget

The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cells

(2016) Sonja Textor et al.   OncoImmunology

RIG-I activation induces the release of extracellular vesicles with antitumor activity

(2016) Juliane Daßler-Plenker et al.   OncoImmunology

NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients

(2016) Sylvie Rusakiewicz et al.   OncoImmunology

Structural basis for collagen recognition by the immune receptor OSCAR

(2015) L. Zhou et al.   BLOOD

Regulation of natural cytotoxicity receptors by heparan sulfate proteoglycans in -cis : A lesson from NKp44

(2015) Michael Brusilovsky et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

B7H6-specific chimeric antigen receptors lead to tumor elimination and host antitumor immunity

(2015) M-R Wu et al.   GENE THERAPY

KIR haplotypes are associated with late-onset type 1 diabetes in European–American families

(2015) J A Traherne et al.   GENES AND IMMUNITY

Cytomegalovirus Infection Drives Adaptive Epigenetic Diversification of NK Cells with Altered Signaling and Effector Function

(2015) Heinrich Schlums et al.   IMMUNITY

Epigenetic Modification and Antibody-Dependent Expansion of Memory-like NK Cells in Human Cytomegalovirus-Infected Individuals

(2015) Jaewon Lee et al.   IMMUNITY

Surveillance of cell and tissue perturbation by receptors in the LRC

(2015) John Trowsdale et al.   IMMUNOLOGICAL REVIEWS

Tissue-Specific Education of Decidual NK Cells

(2015) Andrew M. Sharkey et al.   JOURNAL OF IMMUNOLOGY

B7H6-Specific Bispecific T Cell Engagers Lead to Tumor Elimination and Host Antitumor Immunity

(2015) Ming-Ru Wu et al.   JOURNAL OF IMMUNOLOGY

OSCAR Is a Receptor for Surfactant Protein D That Activates TNF-α Release from Human CCR2+Inflammatory Monocytes

(2015) Alexander D. Barrow et al.   JOURNAL OF IMMUNOLOGY

Group 2 Innate Lymphoid Cells Express Functional NKp30 Receptor Inducing Type 2 Cytokine Production

(2015) Maryam Salimi et al.   JOURNAL OF IMMUNOLOGY

Priming of Human Resting NK Cells by Autologous M1 Macrophages via the Engagement of IL-1β, IFN-β, and IL-15 Pathways

(2015) Irene Mattiola et al.   JOURNAL OF IMMUNOLOGY

A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection

(2015) W. Deng et al.   SCIENCE

Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients

(2015) Michaela Semeraro et al.   Science Translational Medicine

Natural cytotoxicity receptor splice variants orchestrate the distinct functions of human natural killer cell subtypes

(2015) Johan Siewiera et al.   Nature Communications

HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicity

(2015) Matthias Peipp et al.   Oncotarget

NKp44 and Natural Cytotoxicity Receptors as Damage-Associated Molecular Pattern Recognition Receptors

(2015) Nathan C. Horton et al.   Frontiers in Immunology

Natural killer cell mediated immunosurveillance of pediatric neuroblastoma

(2015) Michaela Semeraro et al.   OncoImmunology

Enhancing natural killer cell-mediated lysis of lymphoma cells by combining therapeutic antibodies with CD20-specific immunoligands engaging NKG2D or NKp30

(2015) Christian Kellner et al.   OncoImmunology

B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape

(2015) Silvia Pesce et al.   OncoImmunology

Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes

(2015) Rami Yossef et al.   PLoS One

An NCR1-based chimeric receptor endows T-cells with multiple anti-tumor specificities

(2015) Yair Tal et al.   Oncotarget

High frequency of activated NKp46+natural killer cells in patients with new diagnosed of latent autoimmune diabetes in adults

(2014) Ye Wang et al.   AUTOIMMUNITY

Metalloprotease-Mediated Tumor Cell Shedding of B7-H6, the Ligand of the Natural Killer Cell-Activating Receptor NKp30

(2014) E. Schlecker et al.   CANCER RESEARCH

Conditional ablation of NKp46+cells using a novel Ncr1greenCremouse strain: NK cells are essential for protection against pulmonary B16 metastases

(2014) Leila Ben Merzoug et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Development, Differentiation, and Diversity of Innate Lymphoid Cells

(2014) Andreas Diefenbach et al.   IMMUNITY

TRAIL+ NK Cells Control CD4+ T Cell Responses during Chronic Viral Infection to Limit Autoimmunity

(2014) Iona S. Schuster et al.   IMMUNITY

Nidogen-1: a candidate biomarker for ovarian serous cancer

(2014) Lin Li et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells

(2014) Luzheng Xue et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Tumor-released Galectin-3, a Soluble Inhibitory Ligand of Human NKp30, Plays an Important Role in Tumor Escape from NK Cell Attack

(2014) Wei Wang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Uterine NK cells: active regulators at the maternal-fetal interface

(2014) Ashley Moffett et al.   JOURNAL OF CLINICAL INVESTIGATION

Critical and Differential Roles of NKp46- and NKp30-Activating Receptors Expressed by Uterine NK Cells in Early Pregnancy

(2014) H. El Costa et al.   JOURNAL OF IMMUNOLOGY

Umbilical Cord Blood T Cells Express Multiple Natural Cytotoxicity Receptors after IL-15 Stimulation, but Only NKp30 Is Functional

(2014) Q. Tang et al.   JOURNAL OF IMMUNOLOGY

Influenza Virus Uses Its Neuraminidase Protein to Evade the Recognition of Two Activating NK Cell Receptors

(2014) Y. Bar-On et al.   JOURNAL OF INFECTIOUS DISEASES

Leukocyte-associated Ig-like receptor-1 is a novel inhibitory receptor for surfactant protein D

(2014) Marloes J. M. Olde Nordkamp et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells

(2014) Dorothy K Sojka et al.   eLife

The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics

(2014) Edward Hammond et al.   Frontiers in Oncology

Expression of the Activating Receptor, NKp46 (CD335), in Human Natural Killer and T-Cell Neoplasia

(2013) Aharon G. Freud et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions

(2013) J. Matta et al.   BLOOD

Identification of a cellular ligand for the natural cytotoxicity receptor NKp44

(2013) F. Baychelier et al.   BLOOD

Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity

(2013) K. S. Reiners et al.   BLOOD

The NK Receptor NKp30 Mediates Direct Fungal Recognition and Killing and Is Diminished in NK Cells from HIV-Infected Patients

(2013) Shu Shun Li et al.   Cell Host & Microbe

BAG-6, a jack of all trades in health and disease

(2013) Janina Binici et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Constitutive expression of ligand for natural killer cell NKp44 receptor (NKp44L) by normal human articular chondrocytes

(2013) Agata Białoszewska et al.   CELLULAR IMMUNOLOGY

NKp46 regulates allergic responses

(2013) Hormas Ghadially et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Exploring the genetic basis of chronic periodontitis: a genome-wide association study

(2013) K. Divaris et al.   HUMAN MOLECULAR GENETICS

RORγt+ Innate Lymphoid Cells Acquire a Proinflammatory Program upon Engagement of the Activating Receptor NKp44

(2013) Timor Glatzer et al.   IMMUNITY

Intraepithelial Type 1 Innate Lymphoid Cells Are a Unique Subset of IL-12- and IL-15-Responsive IFN-γ-Producing Cells

(2013) Anja Fuchs et al.   IMMUNITY

A Soluble Fragment of the Tumor Antigen BCL2-associated Athanogene 6 (BAG-6) Is Essential and Sufficient for Inhibition of NKp30 Receptor-dependent Cytotoxicity of Natural Killer Cells

(2013) Janina Binici et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Uterine NK Cells Regulate Endometrial Bleeding in Women and Are Suppressed by the Progesterone Receptor Modulator Asoprisnil

(2013) J. Wilkens et al.   JOURNAL OF IMMUNOLOGY

TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells

(2013) Annamaria Biroccio et al.   NATURE CELL BIOLOGY

Novel Interaction between Proliferating Cell Nuclear Antigen and HLA I on the Surface of Tumor Cells Inhibits NK Cell Function through NKp44

(2013) Nathan C. Horton et al.   PLoS One

Interaction ofMycobacterium tuberculosisCell Wall Components with the Human Natural Killer Cell Receptors NKp44 and Toll-Like Receptor 2

(2013) S. Esin et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

NCR3/NKp30 Contributes to Pathogenesis in Primary Sjogren's Syndrome

(2013) S. Rusakiewicz et al.   Science Translational Medicine

Engagement of NKp30 on V 1 T cells induces the production of CCL3, CCL4, and CCL5 and suppresses HIV-1 replication

(2012) K. Hudspeth et al.   BLOOD

Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell–mediated deletion

(2012) Dimitra Peppa et al.   JOURNAL OF EXPERIMENTAL MEDICINE

An NKp30-Based Chimeric Antigen Receptor Promotes T Cell Effector Functions and Antitumor Efficacy In Vivo

(2012) T. Zhang et al.   JOURNAL OF IMMUNOLOGY

Mimicking an Induced Self Phenotype by Coating Lymphomas with the NKp30 Ligand B7-H6 Promotes NK Cell Cytotoxicity

(2012) C. Kellner et al.   JOURNAL OF IMMUNOLOGY

Recognition and Prevention of Tumor Metastasis by the NK Receptor NKp46/NCR1

(2012) A. Glasner et al.   JOURNAL OF IMMUNOLOGY

Direct Recognition of Fusobacterium nucleatum by the NK Cell Natural Cytotoxicity Receptor NKp46 Aggravates Periodontal Disease

(2012) Stella Chaushu et al.   PLoS Pathogens

Differentiation of human peripheral blood V 1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells

(2011) D. V. Correia et al.   BLOOD

Natural killer cells and T cells induce different types ofskin reactions during recall responses to haptens

(2011) Paul Rouzaire et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human

(2011) Jianhua Yu et al.   JOURNAL OF CLINICAL INVESTIGATION

OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice

(2011) Alexander David Barrow et al.   JOURNAL OF CLINICAL INVESTIGATION

Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6

(2011) Yili Li et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Proliferating Cell Nuclear Antigen Is a Novel Inhibitory Ligand for the Natural Cytotoxicity Receptor NKp44

(2011) B. Rosental et al.   JOURNAL OF IMMUNOLOGY

Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors

(2011) Nicolas F Delahaye et al.   NATURE MEDICINE

Crystal structure of human natural cytotoxicity receptor NKp30 and identification of its ligand binding site

(2011) M. G. Joyce et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Modulation of NKp30- and NKp46-Mediated Natural Killer Cell Responses by Poxviral Hemagglutinin

(2011) Mostafa Jarahian et al.   PLoS Pathogens

Natural killer cells are required for accelerated type 1 diabetes driven by interferon-β

(2010) A. Alba et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Interferon-α–Induced TRAIL on Natural Killer Cells Is Associated With Control of Hepatitis C Virus Infection

(2010) Kerstin A. Stegmann et al.   GASTROENTEROLOGY

Expression and Function of the Natural Cytotoxicity Receptor NKp46 on Circulating Malignant CD4+ T Lymphocytes of Sézary Syndrome Patients

(2010) Armand Bensussan et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Inhibition of Human Natural Killer Cell Activity by Influenza Virions and Hemagglutinin

(2010) H. Mao et al.   JOURNAL OF VIROLOGY

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

(2010) Daniel R. Neill et al.   NATURE

Expansion of human NK-22 cells with IL-7, IL-2, and IL-1  reveals intrinsic functional plasticity

(2010) M. Cella et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Properdin: Emerging Roles of a Pattern-Recognition Molecule

(2009) Claudia Kemper et al.   Annual Review of Immunology

Crystal structure and collagen-binding site of immune inhibitory receptor LAIR-1: unexpected implications for collagen binding by platelet receptor GPVI

(2009) T. H. C. Brondijk et al.   BLOOD

NKp44 expression, phylogenesis and function in non-human primate NK cells

(2009) A. De Maria et al.   INTERNATIONAL IMMUNOLOGY

NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo

(2009) Tadepally Lakshmikanth et al.   JOURNAL OF CLINICAL INVESTIGATION

The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans

(2009) Cameron S. Brandt et al.   JOURNAL OF EXPERIMENTAL MEDICINE

NKp44 Receptor Mediates Interaction of the Envelope Glycoproteins from the West Nile and Dengue Viruses with NK Cells

(2009) O. Hershkovitz et al.   JOURNAL OF IMMUNOLOGY

CD56highCD16-CD62L- NK Cells Accumulate in Allergic Contact Dermatitis and Contribute to the Expression of Allergic Responses

(2009) T. Carbone et al.   JOURNAL OF IMMUNOLOGY

Enhanced In Vivo Growth of Lymphoma Tumors in the Absence of the NK-Activating Receptor NKp46/NCR1

(2009) G. G. Halfteck et al.   JOURNAL OF IMMUNOLOGY

Natural Cytotoxicity Receptors NKp30, NKp44 and NKp46 Bind to Different Heparan Sulfate/Heparin Sequences

(2009) Marie-Lyn Hecht et al.   JOURNAL OF PROTEOME RESEARCH

Effector functions of human decidual NK cells in healthy early pregnancy are dependent on the specific engagement of natural cytotoxicity receptors

(2009) Hicham El Costa et al.   JOURNAL OF REPRODUCTIVE IMMUNOLOGY

Activation of Natural Killer Cells by Newcastle Disease Virus Hemagglutinin-Neuraminidase

(2009) M. Jarahian et al.   JOURNAL OF VIROLOGY

Identification of multiple potent binding sites for human leukocyte associated Ig-like receptor LAIR on collagens II and III

(2009) Robert Jan Lebbink et al.   MATRIX BIOLOGY

The activating receptor NKp46 is essential for the development of type 1 diabetes

(2009) Chamutal Gur et al.   NATURE IMMUNOLOGY

Cellular Expression, Trafficking, and Function of Two Isoforms of Human ULBP5/RAET1G

(2009) Robert A. Eagle et al.   PLoS One

Role of platelet-derived growth factors in physiology and medicine

(2008) J. Andrae et al.   GENES & DEVELOPMENT

The extended human leukocyte receptor complex: diverse ways of modulating immune responses

(2008) Alexander David Barrow et al.   IMMUNOLOGICAL REVIEWS

Direct Binding of Human NK Cell Natural Cytotoxicity Receptor NKp44 to the Surfaces of Mycobacteria and Other Bacteria

(2008) S. Esin et al.   INFECTION AND IMMUNITY

Nidogens—Extracellular matrix linker molecules

(2008) Matthew S.P. HO et al.   MICROSCOPY RESEARCH AND TECHNIQUE

A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity

(2008) Marina Cella et al.   NATURE

Dendritic Cells Release HLA-B-Associated Transcript-3 Positive Exosomes to Regulate Natural Killer Function

(2008) Venkateswara Rao Simhadri et al.   PLoS One

Expression of Ligands to NKp46 in Benign and Malignant Melanocytes

(2007) Emanuela Cagnano et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY